{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Tofacitinib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Tofacitinib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Tofacitinib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "tofacitinib",
    "trial_2_text": "Tofacitinib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Tofacitinib Supplement: 60 participants will take Tofacitinib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Tofacitinib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Tofacitinib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "78": 0.29383647441864014,
      "87": 0.2902836203575134,
      "189": 0.2796878516674042,
      "188": 0.2285231053829193,
      "173": 0.22547248005867004,
      "64": 0.1736900508403778,
      "77": 0.15536944568157196,
      "37": 0.14974316954612732,
      "9": 0.14974139630794525,
      "123": 0.149264395236969,
      "17": 0.14320777356624603,
      "243": 0.1326732486486435,
      "67": 0.1276674121618271,
      "20": 0.12629319727420807,
      "21": 0.12558519840240479,
      "297": 0.12331612408161163,
      "131": 0.11666572093963623,
      "422": 0.11573126912117004,
      "14": 0.1109485775232315,
      "177": 0.108690045773983,
      "2": 0.10377072542905807,
      "46": 0.09839560836553574,
      "228": 0.09819693863391876,
      "193": 0.0977126881480217,
      "79": 0.09719689190387726,
      "104": 0.09355881810188293,
      "200": 0.09302666783332825,
      "114": 0.09273918718099594,
      "5": 0.08978071063756943,
      "341": 0.08518640697002411,
      "186": 0.08505275845527649,
      "92": 0.08421288430690765,
      "99": 0.0836876630783081,
      "239": 0.08367764204740524,
      "76": 0.08355455100536346,
      "116": 0.08288709819316864,
      "151": 0.08202815800905228,
      "49": 0.08136481046676636,
      "68": 0.08124624937772751,
      "350": 0.08082212507724762,
      "191": 0.08061899244785309,
      "261": 0.07954056560993195,
      "355": 0.07897685468196869,
      "85": 0.07863825559616089,
      "101": 0.07464006543159485,
      "132": 0.07425786554813385,
      "130": 0.073226198554039,
      "86": 0.07222064584493637,
      "194": 0.0714791789650917,
      "138": 0.07077281922101974,
      "139": 0.0706404447555542,
      "204": 0.07013186067342758,
      "30": 0.06981929391622543,
      "456": 0.06975766271352768,
      "97": 0.06838296353816986,
      "126": 0.06813566386699677,
      "136": 0.0677122250199318,
      "118": 0.06496673077344894,
      "61": 0.06459216773509979,
      "147": 0.06425046920776367,
      "396": 0.06371579319238663,
      "199": 0.06308550387620926,
      "466": 0.06247541680932045,
      "179": 0.0611584447324276,
      "29": 0.06063232943415642,
      "102": 0.05996684357523918,
      "356": 0.05977514013648033,
      "441": 0.0589803084731102,
      "28": 0.05891131982207298,
      "18": 0.05808918550610542,
      "72": 0.05799543485045433,
      "489": 0.057785823941230774,
      "33": 0.056637976318597794,
      "178": 0.05552072823047638,
      "339": 0.054805077612400055,
      "276": 0.05470667779445648,
      "154": 0.05422515049576759,
      "83": 0.053805992007255554,
      "27": 0.05286750569939613,
      "211": 0.052839383482933044,
      "363": 0.05266399309039116,
      "69": 0.052508339285850525,
      "38": 0.05218854919075966,
      "382": 0.05201253294944763,
      "4": 0.05117892846465111,
      "144": 0.05107025429606438,
      "257": 0.050908543169498444,
      "371": 0.05063959211111069,
      "288": 0.04998176172375679,
      "82": 0.0494363009929657,
      "35": 0.04883129522204399,
      "747": 0.04843401163816452,
      "11": 0.04806572571396828,
      "454": 0.047207143157720566,
      "122": 0.0471898578107357,
      "98": 0.04703919589519501,
      "75": 0.04692700877785683,
      "105": 0.04641253128647804,
      "195": 0.04596381634473801,
      "269": 0.04467505216598511
    },
    "trial_2_ae": {
      "78": 0.29383647441864014,
      "87": 0.2902836203575134,
      "189": 0.2796878516674042,
      "188": 0.2285231053829193,
      "173": 0.22547248005867004,
      "64": 0.1736900508403778,
      "77": 0.15536944568157196,
      "37": 0.14974316954612732,
      "9": 0.14974139630794525,
      "123": 0.149264395236969,
      "17": 0.14320777356624603,
      "243": 0.1326732486486435,
      "67": 0.1276674121618271,
      "20": 0.12629319727420807,
      "21": 0.12558519840240479,
      "297": 0.12331612408161163,
      "131": 0.11666572093963623,
      "422": 0.11573126912117004,
      "14": 0.1109485775232315,
      "177": 0.108690045773983,
      "2": 0.10377072542905807,
      "46": 0.09839560836553574,
      "228": 0.09819693863391876,
      "193": 0.0977126881480217,
      "79": 0.09719689190387726,
      "104": 0.09355881810188293,
      "200": 0.09302666783332825,
      "114": 0.09273918718099594,
      "5": 0.08978071063756943,
      "341": 0.08518640697002411,
      "186": 0.08505275845527649,
      "92": 0.08421288430690765,
      "99": 0.0836876630783081,
      "239": 0.08367764204740524,
      "76": 0.08355455100536346,
      "116": 0.08288709819316864,
      "151": 0.08202815800905228,
      "49": 0.08136481046676636,
      "68": 0.08124624937772751,
      "350": 0.08082212507724762,
      "191": 0.08061899244785309,
      "261": 0.07954056560993195,
      "355": 0.07897685468196869,
      "85": 0.07863825559616089,
      "101": 0.07464006543159485,
      "132": 0.07425786554813385,
      "130": 0.073226198554039,
      "86": 0.07222064584493637,
      "194": 0.0714791789650917,
      "138": 0.07077281922101974,
      "139": 0.0706404447555542,
      "204": 0.07013186067342758,
      "30": 0.06981929391622543,
      "456": 0.06975766271352768,
      "97": 0.06838296353816986,
      "126": 0.06813566386699677,
      "136": 0.0677122250199318,
      "118": 0.06496673077344894,
      "61": 0.06459216773509979,
      "147": 0.06425046920776367,
      "396": 0.06371579319238663,
      "199": 0.06308550387620926,
      "466": 0.06247541680932045,
      "179": 0.0611584447324276,
      "29": 0.06063232943415642,
      "102": 0.05996684357523918,
      "356": 0.05977514013648033,
      "441": 0.0589803084731102,
      "28": 0.05891131982207298,
      "18": 0.05808918550610542,
      "72": 0.05799543485045433,
      "489": 0.057785823941230774,
      "33": 0.056637976318597794,
      "178": 0.05552072823047638,
      "339": 0.054805077612400055,
      "276": 0.05470667779445648,
      "154": 0.05422515049576759,
      "83": 0.053805992007255554,
      "27": 0.05286750569939613,
      "211": 0.052839383482933044,
      "363": 0.05266399309039116,
      "69": 0.052508339285850525,
      "38": 0.05218854919075966,
      "382": 0.05201253294944763,
      "4": 0.05117892846465111,
      "144": 0.05107025429606438,
      "257": 0.050908543169498444,
      "371": 0.05063959211111069,
      "288": 0.04998176172375679,
      "82": 0.0494363009929657,
      "35": 0.04883129522204399,
      "747": 0.04843401163816452,
      "11": 0.04806572571396828,
      "454": 0.047207143157720566,
      "122": 0.0471898578107357,
      "98": 0.04703919589519501,
      "75": 0.04692700877785683,
      "105": 0.04641253128647804,
      "195": 0.04596381634473801,
      "269": 0.04467505216598511
    }
  },
  "safety": {
    "trial_1_safety": 0.24992045760154724,
    "trial_2_safety": 0.24992045760154724
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4817916750907898
  }
}